Related Experiment Video
Updated: Jul 7, 2026

A Murine Model of Group B Streptococcus Vaginal Colonization
Published on: November 16, 2016
[Vertebral osteomyelitis due to Streptococcus agalactiae ST-17]
C Martinaud1, T Gaillard, B Graffin
1Laboratoire de biologie, Hôpital d'instruction des armées Sainte-Anne, Toulon. martinaud_christophe@yahoo.fr
Abstract:
Streptococcus agalactiae has been traditionally considered as associated with neonates and pregnant women. Invasive diseases due to Streptococcus agalactiae are increasing in non-pregnant adults, especially with medical underlying conditions such as diabetes mellitus or neoplasia. Among these invasive manifestations, vertebral osteomyelitis remain exceptional. We report the case of a 49 year old man, without any risk factor, suffering from a vertebral osteomyelitis due to Streptococcus agalactiae. Assessment of virulence factors showed that the strain belonged to the serotype III, sequence type ST-17. The patient recovered well after prolonged antibiotic therapy. Although exceptional and associated with a favourable outcome, this case highlights the potential implication of Group B Streptococcus in vertebral osteomyelitis and the way to manage it.
Insights
Group B Streptococcus (GBS) vertebral osteomyelitis is rare in healthy adults. This case report details a successful treatment of GBS vertebral osteomyelitis in a 49-year-old man, highlighting GBS
Area of Science:
- Infectious Diseases
- Microbiology
- Clinical Medicine
Background:
- Streptococcus agalactiae, or Group B Streptococcus (GBS), is primarily associated with neonatal and maternal infections.
- Invasive GBS infections are increasingly reported in non-pregnant adults, particularly those with comorbidities like diabetes or cancer.
- Vertebral osteomyelitis caused by GBS is an uncommon manifestation of invasive disease.
Observation:
- A case of vertebral osteomyelitis caused by Streptococcus agalactiae in a 49-year-old male patient with no apparent risk factors is presented.
- The infecting strain was identified as serotype III, sequence type ST-17, indicating specific virulence characteristics.
- The patient received prolonged antibiotic therapy.
Findings:
- The study confirms the potential for Streptococcus agalactiae to cause vertebral osteomyelitis in otherwise healthy adults.
- Virulence factor assessment identified the strain as serotype III, ST-17.
- The patient experienced a favorable outcome following extended antibiotic treatment.
Implications:
- This case underscores the importance of considering GBS as a causative agent for vertebral osteomyelitis, even in the absence of typical risk factors.
- Early diagnosis and appropriate management, including prolonged antibiotic therapy, are crucial for favorable outcomes.
- Further research may elucidate the specific mechanisms and risk factors associated with GBS vertebral osteomyelitis in the adult population.
Related Concept Videos
Bacterial Meningitis
Streptococcal Pharyngitis
Cryptococcal Meningitis
Bacterial Meningitis I: Introduction
Bacterial Meningitis II: Pathophysiology
Acute Pyelonephritis II: Diagnostic Studies and Management
